Analysis and Forecast to 2030 by Recent Trends, Consumption by Regional Data, Investigation and Growth, Developments in Manufacturing Technology and Growth Overview for Lyme disease Diagnostics Market.

2 minutes, 39 seconds Read


The market for Lyme disease diagnostics was valued at US$ 2 billion in 2020 and is projected to reach US$ 2.95 billion by 2030, growing at a CAGR of 4.4% The Borrelia burgdorferi bacteria is the cause of the tick-borne illness Lyme disease. With an estimated 300,000 new cases reported annually in the US alone, it is the most prevalent vector-borne disease in both the US and Europe. For long-term health and complications prevention, early diagnosis and treatment are essential. The market for Lyme disease diagnostics consists of a variety of instruments and tests for identifying the bacterium and antibodies the body produces in response to infection. These diagnostic procedures include polymerase chain reaction (PCR), culture, and serology tests. Diagnostic laboratories, test kits for Lyme disease, and other associated services are also available on the market as diagnostic tools. The market for Lyme disease diagnostics is fueled by rising disease awareness.

Download this Report’s Sample Copy:

Market Segmentation:

 Lyme disease diagnostics market by type:

  • Serological Tests
  • Urine Antigen Tests
  • Lymphocytic Transformation Tests
  • Immunofluorescent Staining
  • Nucleic Acid Tests

 Lyme disease diagnostics market by application:

  • Hospitals
  • Clinics

 Lyme disease diagnostics market by region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key players in the Lyme disease diagnostics market include:

  • Abbott Laboratories
  • Alere Inc.
  • Bio-Rad
  • Canon Life Sciences
  • Global Lyme Diagnostics
  • Graphene Frontiers
  • Oxford Immunities
  • Trinity Biotech

Download this Report’s PDF Copy:

  • Some frequently asked questions (FAQs) about the Lyme disease diagnostics market: 
  1. What typical issues does the market for diagnosing Lyme illness face?

The market for diagnosing Lyme disease frequently faces difficulties such as low diagnostic test accuracy, variation in symptoms and test outcomes, and a lack of knowledge of the illness among medical professionals.

  1. What is benefits of Lyme disease diagnostics market?
  • Early detection and treatment: If neglected, Lyme disease can cause major long-term health issues. The risk of problems can be decreased by early detection and prompt treatment made possible by the availability of accurate and reliable diagnostic tests.
  • Improved patient outcomes: Patient outcomes and quality of life can be enhanced by prompt diagnosis and treatment.
  • Increased awareness of the disease: The market for Lyme disease diagnostics has helped raise awareness of the condition and any potential side effects, which has improved management and prevention techniques.
  • Development of new diagnostic technologies: The market for Lyme disease diagnostics has sparked the creation of cutting-edge diagnostic tools that can deliver more precise and dependable results, including quick diagnostic tests and sophisticated imaging techniques.

Other related reports:

About us:

Prophecy Market Insights is specialized market research, marketing/business strategy, analytics, and solutions that offer strategic support to clients for making well-informed business decisions and identifying and achieving high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome transform and advance their businesses with growth.

To know more

Contact Us:


Prophecy Market Insights

📞+1 860 531 2574


🌐 Website-

Follow us on:

LinkedIn | Twitter | Facebook


Your Missed